We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

157 hedge funds and large institutions have $2.55B invested in MyoKardia, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

21% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 47

13% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 23

7% more capital invested

Capital invested by funds: $2.39B → $2.55B (+$161M)

1% more funds holding

Funds holding: 155 → 157 (+2)

19% less call options, than puts

Call options by funds: $4.77M | Put options by funds: $5.89M

Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
3.44%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
26
Increased
57
Reduced
47
Closed
23
Calls
$4.77M
Puts
$5.89M
Net Calls
-$1.12M
Net Calls Change
+$524K

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$26.6M
2
Norges Bank
Norges Bank
Norway
+$17.2M
3
Fidelity International
Fidelity International
Bermuda
+$15.2M
4
BlackRock
BlackRock
New York
+$14.6M
5
DCM
Driehaus Capital Management
Illinois
+$9.56M

Top Sellers

1
PHS
PFM Health Sciences
California
-$29.2M
2
Millennium Management
Millennium Management
New York
-$13.1M
3
O
OrbiMed
New York
-$9.16M
4
CC
Casdin Capital
New York
-$9.04M
5
SFM
Sphera Funds Management
Israel
-$7.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
NIP
51
Nicholas Investment Partners
California
$5.06M -$43.7K -821 -0.8%
Victory Capital Management
52
Victory Capital Management
Texas
$5M +$3.49M +65,656 +217%
Marshall Wace
53
Marshall Wace
United Kingdom
$4.91M -$4.57M -85,946 -48%
American Century Companies
54
American Century Companies
Missouri
$4.72M +$4.82M +90,611 New
GC
55
Grace Capital
Massachusetts
$4.46M -$452K -8,500 -9%
SIM
56
Spark Investment Management
New York
$4.32M -$6.56M -123,400 -60%
Swiss National Bank
57
Swiss National Bank
Switzerland
$4.3M +$133K +2,500 +3%
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$4.29M +$3.33M +62,690 +321%
Dimensional Fund Advisors
59
Dimensional Fund Advisors
Texas
$3.8M +$3.17M +59,605 +449%
Axa
60
Axa
France
$3.71M +$3.78M +71,098 New
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$3.61M +$44K +827 +1%
State of Wisconsin Investment Board
62
State of Wisconsin Investment Board
Wisconsin
$3.48M +$920K +17,300 +35%
TD Asset Management
63
TD Asset Management
Ontario, Canada
$3.47M +$160K +3,004 +5%
GH
64
GAM Holding
Switzerland
$3.36M +$1.25M +23,500 +57%
MCM
65
Moore Capital Management
New York
$3.36M +$219K +4,109 +7%
CS
66
Candriam SCA
Luxembourg
$3.18M – – –
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$3.09M +$47.4K +891 +2%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$2.79M +$101K +1,900 +4%
Handelsbanken Fonder
69
Handelsbanken Fonder
Sweden
$2.76M +$532K +10,000 +23%
ACM
70
Asymmetry Capital Management
California
$2.5M -$4.19M -78,753 -62%
State of New Jersey Common Pension Fund D
71
State of New Jersey Common Pension Fund D
New Jersey
$2.36M +$2.4M +45,200 New
Bank of America
72
Bank of America
North Carolina
$2.35M -$1.32M -24,900 -36%
Citadel Advisors
73
Citadel Advisors
Florida
$2.25M +$701K +13,175 +44%
UBS AM
74
UBS AM
Illinois
$2.18M +$246K +4,626 +12%
Morgan Stanley
75
Morgan Stanley
New York
$2.17M +$1.39M +26,142 +169%
1 2
3
4 5

MYOK Hedge Fund Activity: Q3 2019 in Review

157 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2019, worth a combined $2.55B — up 6.7% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MYOK positions and 23 closed out — a net gain of 3 holders — while 57 added to existing stakes and 47 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $26.6M. The largest seller was PFM Health Sciences, cutting an estimated $29.2M.

  • 157 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2019, up from 155 in Q2 2019.
  • Funds reported $2.55B of MyoKardia, Inc. Common Stock stock for Q3 2019, up 6.7% quarter-over-quarter.
  • 26 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2019 and 23 closed out, a net change of +3 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q3 2019 was Baker Bros. Advisors, an estimated $26.6M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q3 2019 was PFM Health Sciences, an estimated $29.2M sold.

Based on aggregated 13F filings for Q3 2019.